Tech stocks reach record, bond yields rise again
January 29, 2018U.S. authorities due to make arrests in futures ‘spoofing’ probe: sources
January 29, 2018Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
at
PARIS/LONDON (Reuters) – French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.
Powered by WPeMatico
